In parallel, other circulating mediators including GDF-15, IL-6, and skeletal-muscle-derived myokines have been identified as systemic biomarkers that reflect inflammation-, metabolism-, and aging-related pathways contributing to COPD’s extrapulmonary manifestations [25]. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.